PTC Therapeutics to Host Conference Call to Discuss First Quarter 2020 Financial Results

PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the Company will host a webcast conference call to report its first quarter 2020 financial results and provide an update on the company’s business and outlook on Thursday, April 30, 2020 at 4:30 p.m. (ET) after the closing of the market. The call can

SOUTH PLAINFIELD, N.J., April 16, 2020 /PRNewswire/ --PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the Company will host a webcast conference call to report its first quarter 2020 financial results and provide an update on the company’s business and outlook on Thursday, April 30, 2020 at 4:30 p.m. (ET) after the closing of the market.

The call can be accessed by dialing (877) 303-9216 (domestic) or (973) 935-8152 (international) five minutes prior to the start of the call and providing the passcode 8267466. A live, listen-only webcast of the conference call can be accessed on the investor relations section of the PTC website at www.ptcbio.com. A webcast replay of the call will be available approximately two hours after completion of the call and will be archived on the company’s website for 30 days following the call.

About PTC Therapeutics, Inc.
PTC is a science-driven, global biopharmaceutical company focused on the discovery, development and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. PTC’s ability to globally commercialize products is the foundation that drives investment in a robust and diversified pipeline of transformative medicines and our mission to provide access to best-in-class treatments for patients who have an unmet medical need.

FOR MORE INFORMATION PLEASE CONTACT:

Media:

Investors:

Jane Baj

Alex Kane

+1 (908) 912-9167

+1 (908) 912-9643

jbaj@ptcbio.com

akane@ptcbio.com

Cision View original content:http://www.prnewswire.com/news-releases/ptc-therapeutics-to-host-conference-call-to-discuss-first-quarter-2020-financial-results-301040545.html

SOURCE PTC Therapeutics, Inc.


Company Codes: NASDAQ-NMS:PTCT
MORE ON THIS TOPIC